Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Violacein Extracted from Chromobacterium violaceum Inhibits Plasmodium Growth In Vitro and In Vivo

Full text
Author(s):
Show less -
Lopes, Stefanie C. P. [1] ; Blanco, Yara C. [1] ; Justo, Giselle Z. [2] ; Nogueira, Paulo A. [3] ; Rodrigues, Francisco L. S. [3] ; Goelnitz, Uta [4] ; Wunderlich, Gerhard [4] ; Facchini, Gustavo [5] ; Brocchi, Marcelo [1] ; Duran, Nelson [6] ; Costa, Fabio T. M. [1, 7]
Total Authors: 11
Affiliation:
[1] Univ Estadual Campinas, UNICAMP, Dept Microbiol & Imunol, Inst Biol, BR-13083970 Campinas, SP - Brazil
[2] Univ Fed Sao Paulo, UNIFESP, Dept Bioquim, BR-04044020 Sao Paulo - Brazil
[3] CEPEM, IPEPATRO, BR-78900970 Porto Velho, RO - Brazil
[4] Univ Sao Paulo, Dept Parasitol, ICB2, Sao Paulo - Brazil
[5] Univ Estadual Campinas, Dept Fisiol & Biofis, Inst Biol, BR-13083970 Campinas, SP - Brazil
[6] Univ Estadual Campinas, Lab Quim Biol, Inst Quim, BR-13083970 Campinas, SP - Brazil
[7] Univ Estadual Campinas, UNICAMP, Dept Parasitol, Inst Biol, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 7
Document type: Journal article
Source: Antimicrobial Agents and Chemotherapy; v. 53, n. 5, p. 2149-2152, MAY 1 2009.
Web of Science Citations: 50
Abstract

Violacein is a violet pigment extracted from the gram-negative bacterium Chromobacterium violaceum. It presents bactericidal, tumoricidal, trypanocidal, and antileishmanial activities. We show that micromolar concentrations efficiently killed chloroquine-sensitive and -resistant Plasmodium falciparum strains in vitro; inhibited parasitemia in vivo, even after parasite establishment; and protected Plasmodium chabaudi chabaudi-infected mice from a lethal challenge. (AU)

FAPESP's process: 04/00638-6 - Analysis of the immune response against surface antigens of human erythrocytes infected by Plasmodium spp.: emphasis on the improvement of vaccines and development of monoclonal antibodies
Grantee:Fabio Trindade Maranhão Costa
Support Opportunities: Research Grants - Young Investigators Grants